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Barriers and facilitators to further development of the
paramedic role during assessment of suspected stroke
patients
Lally J1, Flynn D1, Ford G2, Price C3, Exley C1
1Institute of Health and Society, Newcastle University,
Newcastle, UK
2Oxford University Hospitals NHS Trust, Oxford, UK
3Institute of Neuroscience, Newcastle University, Newcastle,
UK
Introduction: Actions by paramedics before and during initial hospital
assessment are an opportunity to reduce delays to brain imaging and
thrombolysis for patients with suspected stroke. This qualitative study
explored professional views regarding the barriers and facilitators to the
enhancement of the paramedic role.
Method: A purposive sample of 103 paramedics and stroke/A&E clini-
cians participated in 15 focus groups across the North East, North West
and Wales. Focus groups about pre and post-admission roles were digitally
recorded and transcribed verbatim. Data were analysed using open then
focused coding to identify barriers and facilitators to enhanced paramedic
involvement along the stroke patient care pathway.
Results: Paramedics welcomed the possibility of an enhanced role which
provided opportunities for skills development and enhanced professional
identity. Hospital teams felt that paramedics helping with ongoing assess-
ment in hospital would benefit patients. Paramedics felt that they were
capable of undertaking more detailed clinical assessments, but unsure
whether their experience and skills were recognised by hospital teams.
Several operational issues were identified as barriers to an enhanced role
e.g. inability to register patient information on the hospital electronic
administration system en-route thus impeding an early brain imaging
request. All participants were uncertain about the feasibility of paramedics
spending extra time in hospital due to the wider implications for ambu-
lance service response times.
Discussion: An enhanced paramedic role was viewed as a positive change
in terms of paramedic professionalism and patient care. However, a
number of operational barriers need to be addressed to facilitate more
effective implementation.
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24/7 Hyperacute stoke care in London: Variation in
health outcomes and processes of care between
in-hours and out-of-hours admission
Melnychuk M1, Morris S1, Baim-Lance A1, Black G1, Brown M1,
Eng J2, Fulop N1, Ramsay A1, Simister R2
1Department of Applied Health Research, University College
London, London, UK
2University College London Hospitals NHS Foundation Trust,
London, UK
Introduction: Evidence suggests outcomes among stroke patients admit-
ted to hospital outside working hours (OOH) are poorer than those
admitted in working hours (IH), though differences are smaller at spe-
cialist stroke units. We examined whether time of admission to 8 Hyper-
acute Stroke Units (HASUs) in London was associated with health
outcomes and processes of care.
Method: Regression analysis using data from 7,094 patients admitted to 8
London HASUs in the 2014 Sentinel Stroke National Audit Programme.
IH was defined as admission 08.30–17.30 Monday-Friday. Health out-
comes were: Modified Rankin Score (mRS) >2 at discharge from HASU
and hospital and inpatient mortality. Care processes were: brain scan <1h
and <12h of admission; admission to stroke bed <4h; swallow screen <4h;
assessment by a Stroke Consultant and Stroke Nurse, both <24h; formal
swallow assessment <72h; treatment with intravenous thrombolysis. We
controlled for HASU, age, sex, type of stroke, comorbidities, and method
of admission.
Results: The adjusted probability of mRS > 2 at discharge from HASU
and hospital, and inpatient mortality, were not significantly different IH
and OOH (all p > 0.29). The probability of brain scan <1h (IH = 0.59;
OOH = 0.62; p = 0.03), admission to a stroke bed <4h (IH = 0.62;
OOH = 0.68; p < 0.001) and swallow screen <4h (IH = 0.73; OOH = 0.76;
p = 0.006 were greater OOH; the probability of brain scan <12h was
greater IH (IH = 0.97; OOH = 0.96, p < 0.001). Other measures were not
different IH and OOH.
Discussion: Among patients admitted to London HASUs there were some
differences in care processes between those admitted IH and OOH, but no
differences in health outcomes while in hospital.
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Patient factors that influence variation in clinical
decision-making about thrombolysis in the treatment
of acute ischaemic stroke: Results of a discrete choice
experiment
De Brún A1, Flynn D1, Ternent L1, Price C2,3, Rodgers H2,3, Ford G4,
Rudd M2,3, Lancsar E5, Simpson S6, Teah J6, Thomson R1
1Institute of Health and Society, Newcastle University,
Newcastle, UK
2Northumbria Healthcare NHS Foundation Trust, North
Shields, UK
3Institute of Neuroscience (Stroke Research Group), Newcastle
University, Newcastle, UK
4Oxford University Hospitals NHS Trust, Oxford, UK
5Centre for Health Economics, Monash University, Melbourne,
Australia
6The Stroke Association, Gateshead, Tyne and Wear, UK
Introduction: Intravenous thrombolysis treatment rates for acute ischae-
mic stroke vary across the UK, despite implementation of 24/7 hyper-
acute stroke services. This may reflect differences in clinical decision-
making on when to offer thrombolysis. We explored factors influencing
clinical decision-making in this setting.
Method: A discrete choice experiment (DCE) using hypothetical patient
vignettes, with variation in 9 patient factors, was conducted with clini-
cians involved in thrombolysis decisions.
Results: 138 clinicians responded. 7 patient factors were individually pre-
dictive of increased likelihood of offering thrombolysis (compared to
reference levels in brackets): stroke onset time 2hours 30minutes
(50mins), pre-stroke dependency mRS3 (mRS4), systolic blood pressure
185 mm/Hg (140 mm/Hg), stroke severity scores of NIHSS 5 without
aphasia, NIHSS 14 and NIHSS 23 (NIHSS 2 without aphasia), age 85 (65),
Afro-Caribbean (white). Factors predictive of not offering thrombolysis
were; age 95, stroke onset time 4hours 15minutes, severe dementia (no
memory problems), SBP 200 mm/Hg.
Discussion: There was considerable heterogeneity amongst respondents
in thrombolysis decision-making, indicating that clinicians differ in their
thresholds for treatment across a number of patient-related factors. Cli-
nicians may delay decisions for patients presenting early (<60mins),
perhaps indicating this is an unfamiliar presentation or that they may wait
to see if symptoms resolve or blood pressure stabilises before decision-
making. That respondents were less likely to offer thrombolysis to patients
with mild stroke may reflect uncertainty/lack of data around treatment
benefit. These findings add to our understanding of decision-making and
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our capacity to improve it further through using the findings to inform
training/CPD and future research.
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Busting the hype: Estimating how many of our
patients might benefit from thrombectomy
Kearney R, Griffiths M, Nadesalingam V, Cohen D, Bathula R
Hyper-Acute Stroke Unit, Northwick Park Hospital, London,
UK
Introduction: Intra-arterial thrombectomy has emerged as an effective
treatment in acute ischaemic stroke. We aimed to identify the potential
impact of this therapy on patients treated at Northwick Park Hospital, a
busy Hyper-Acute Stroke Unit.
Method: The MR CLEAN, EXTEND-IA, ESCAPE, REVASCAT and
SWIFT PRIME trial inclusion and exclusion criteria were used to create a
local protocol for patient selection. This protocol was compared against a
database of our stroke admissions in the first quarter of 2015 to identify
patients who may have benefited from thrombectomy.
Results: Selection criteria included age ≥ 18yrs, pre-morbid modified
Rankin Scale of 0 or 1, presentation ≤ 6 hours of symptom onset, NIHSS
≥ 5, normal coagulation and ASPECTS ≥ 7. All trials selected patients with
thrombi in the major intracranial vessels such as the internal carotid
arteries and the first 2 segments of the middle cerebral arteries. As CT
angiogram and perfusion studies are not done routinely on admission, it
was not possible to select only these patients. 311 stroke patients were
admitted, of which 265 were ischaemic. Of these, 23 were eligible for
thrombectomy using the above criteria (9%). Only 5 of 23 (2%) had
radiological evidence of a suitable thrombus on a non-contrast CT head.
Discussion: At Northwick Park Hospital up to 9% of acute ischaemic
stroke patients may be eligible for intra-arterial therapy. After the appli-
cation of CT angiogram and CT perfusion criteria, this number is likely to
shrink further.
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Intracranial haemorrhage following IV thrombolytic
therapy for acute ischaemic stroke in patients with an
incidental intracranial aneurysm: A systematic review
of the literature
Brolly J1, Collins P1, Dani, K2
1University of Glasgow, Glasgow, UK
2Institute of Neuroscience and Psychology, University of
Glasgow, Glasgow, UK
Introduction: Intravenous (IV) thrombolysis is now regarded as standard
therapy for acute ischaemic stroke. The presence of un-ruptured intrac-
ranial aneurysms is stated as a contraindication to thrombolytic therapy
due to a theoretical increased risk of intracranial haemorrhage. With
increased pre-thrombolysis imaging, more incidental un-ruptured aneu-
rysms are being identified in patients otherwise suitable for thrombolytic
therapy. We conducted a systematic review to identify the rate of intrac-
ranial haemorrhage in patients with a pre-existing intracranial arterial
aneurysm, who received IV thrombolytic therapy for acute ischaemic
stroke.
Methods: 2 reviewers agreed on a comprehensive search strategy, covering
PUBMED and Cochrane library databases to identify appropriate publi-
cations. Both reviewers screened abstracts for relevance, and full text of
relevant abstracts were double-reviewed before final data extraction.
Results: 234 publications were identified, of which 82 relevant abstracts
were reviewed. Full text review revealed 10 relevant papers (4 case reports,
3 retrospective cohort studies, 3 case series). From these 10 publications,
57 patients underwent IV thrombolysis for acute ischaemic stroke and had
an incidental intracranial aneurysm. 6 (10.5%. 95% CI: 2.6%–18.5%)
patients experienced intracranial haemorrhage following IV thrombolytic
therapy.
Discussion: The reported rate for intracranial haemorrhage in all patients
receiving IV thrombolysis for ischaemic stroke is 5.2% (n = 137/2639).
The reported rate of intracranial haemorrhage in the general population
receiving IV thrombolysis is not significantly different from that in our
reported cohort (5.2% vs 10.5% p = 0.075). Our data suggests that
IV-thrombolytic therapy may be safe in acute ischaemic stroke patients
with an incidentally discovered intracranial aneurysm.
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Outcome comparison between patients suffering a
stroke/TIA or a moderate/major bleed: Data from the
‘Triple Antiplatelets for Reducing Dependency after
Ischaemic Stroke’ (TARDIS) trial
Woodhouse L, Krishnan K, Sprigg N, Bath P for the TARDIS
Investigators
Division of Clinical Neuroscience, University of Nottingham,
Nottingham, UK
Introduction: After ischaemic stroke (IS) or TIA, recurrence and
moderate/major bleeding are each associated with worse outcome. We
compared baseline characteristics and outcomes for patients who did and
did not have recurrence or bleeding using data from the ongoing TARDIS
trial.
Method: TARDIS is assessing the safety and efficacy of intensive vs guide-
line antiplatelet agents in 4,100 patients with acute non-cardioembolic IS
or TIA. Information on bleeding is collected up to day 90. Recurrent IS
and TIA events and functional outcome are assessed centrally with blind-
ing to treatment assignment at day 90. Data are unadjusted odds ratio
(OR) or mean difference (MD) with 95% confidence interval (CI).
Results: In 2541 recruited patients, recurrent events (166) were more
common in patients with a qualifying event of TIA (p = 0.038). Con-
versely, moderate/major bleeding (68) was more common in patients with
a qualifying event of stroke (p = 0.046). Patients with a recurrent or
moderate/major bleeding event had worse outcomes at day 90 than those
without such events, with: more deaths (both p < 0.001), dependency
(modified Rankin Scale, both p < 0.001), disability (Barthel Index, both
p < 0.001), cognitive impairment (TICS-M, both p < 0.001), worse quality
of life (EQ-5D HUS, recurrence p < 0.001, bleeding p = 0.002) and more
mood disturbance (Zung depression scale, both p < 0.001).
Discussion: Recurrent events are more common after TIA, and bleeding
after stroke. Both events are associated with a worse outcome.
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